PUBLIC UNIVERSITY CORP YOKOHAM has a total of 13 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MIND NRG SA, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE) and INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | China | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines | |
#5 | Macromolecular chemistry and polymers | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Unspecified technologies | |
#6 | Peptides | |
#7 | Microbiology | |
#8 | Measuring microorganism processes | |
#9 | Special macromolecular compounds | |
#10 | New plants |
# | Name | Total Patents |
---|---|---|
#1 | Zheng Yun-Wen | 3 |
#2 | Taniguchi Hideki | 3 |
#3 | Shirotake Shoichi | 2 |
#4 | Fukuda Motohiro | 2 |
#5 | Kosaka Tomoko | 2 |
#6 | Tazaki Go | 2 |
#7 | Tsuruta Hitoshi | 2 |
#8 | Endo Itaru | 1 |
#9 | Kobiyama Kouji | 1 |
#10 | Park Sam-Yong | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010044468A1 | Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus | |
WO2010044474A1 | Therapeutic agent for hepatitis c | |
WO2010041617A1 | Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2 | |
WO2010024118A1 | Novel recombinant protein having caspase recruitment domain applied thereto, and use thereof | |
WO2009096443A1 | Novel method of highly efficiently isolating fungal and/or plant mutants by clarifying quenching process of singlet oxygen and enhancing molecules participating in the process | |
CN101959523A | Antimicrobial agent for gram-positive bacteria | |
WO2009084472A1 | Method for detecting intractable epilepsy developed in neonatal period and infancy | |
WO2009048081A1 | Method, apparatus and program for diagnosis of fatty liver disease, and method for screening of therapeutic agent for fatty liver disease |